BIOMAT Database Logo BIOMAT Database Logo

[Agranulocytosis during treatment with tuberculostatic preparations]. 1969

I E Fedorova

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013882 Thiosemicarbazones Thiosemicarbazone

Related Publications

I E Fedorova
[Agranulocytosis and toxic hepatic dystrophy during treatment with tuberculostatic drugs].
January 1972, Arkhiv patologii,
I E Fedorova
[Allergy to tuberculostatic preparations].
January 1970, Problemy tuberkuleza,
I E Fedorova
[Agranulocytosis during treatment with mianserin].
January 1981, Therapie,
I E Fedorova
Agranulocytosis during treatment with mefloquine.
April 1991, Lancet (London, England),
I E Fedorova
Agranulocytosis during treatment with pacatal.
November 1956, Lancet (London, England),
I E Fedorova
[Agranulocytosis during treatment with ajmaline].
April 1986, Ugeskrift for laeger,
I E Fedorova
Agranulocytosis during treatment with chlozapine.
March 1977, European journal of clinical pharmacology,
I E Fedorova
Agranulocytosis during treatment with fluconazole.
November 1992, The Journal of international medical research,
I E Fedorova
Agranulocytosis during treatment with methylpromazine.
November 1957, The American journal of psychiatry,
I E Fedorova
[The treatment of pulmonary tuberculosis with intravenous injections of tuberculostatic preparations].
April 1967, Vrachebnoe delo,
Copied contents to your clipboard!